Avelumab: First Drug Ever Approved for Merkel Cell Carcinoma Avelumab: First Drug Ever Approved for Merkel Cell Carcinoma
Patients who develop this rare but aggressive skin cancer have not had a specific therapy, until today ' s approval of a novel immunotherapy.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Hematology | Immunotherapy | Merkel Cell Carcinoma | Skin | Skin Cancer